BATE KENNETH — SEC Form 4 filings
SEC reporting owner CIK 1210238. 9 Form 4 filings on record with FilingPulse; latest filed 2026-01-23.
Transaction summary — filings shown
Covers all 9 filings on record, filed 2024-04-03 to 2026-01-23. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 43 legs across 4 filings — 79,064 shares, $27,023,120 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 33.
- Largest priced transaction: sale of 8,545 shares @ $355.08 ($3,034,150) in MADRIGAL PHARMACEUTICALS, INC., filed 2025-02-28.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | Director | 6 | — | 43 legs · 79,064 sh · $27,023,120 | 26 |
| Astria Therapeutics, Inc. (ATXS) | Director | 3 | — | — | 7 |
Form 4 filings — BATE KENNETH
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-01-23 | 4 | Astria Therapeutics, Inc. (ATXS) | Disposition to issuer (D): 16,666 (derivative) · Disposition to issuer (D): 8,333 (derivative) · Disposition to issuer (D): 14,100 (derivative) · Disposition to issuer (D): 14,100 (derivative) · Disposition to issuer (D): 26,550 (derivative) | EDGAR |
| 2025-11-07 | 4 | MADRIGAL PHARMACEUTICALS, INC. (MDGL) | Option exercise (M): 5,470 @ $9.45 · Option exercise (M): 10,000 @ $303.79 · Option exercise (M): 1,105 @ $280.04 · Sale (S): 1,763 @ $480.24 · Sale (S): 3,259 @ $481.13 · Sale (S): 1,284 @ $482.41 · +11 more | EDGAR |
| 2025-08-15 | 4 | MADRIGAL PHARMACEUTICALS, INC. (MDGL) | Option exercise (M): 10,000 @ $16.46 · Sale (S): 2,317 @ $363.41 · Sale (S): 2,516 @ $364.24 · Sale (S): 2,567 @ $365.33 · Sale (S): 600 @ $366.14 · Sale (S): 1,104 @ $367.63 · +2 more | EDGAR |
| 2025-06-24 | 4 | MADRIGAL PHARMACEUTICALS, INC. (MDGL) | Grant/award (A): 715 @ $0 · Grant/award (A): 1,290 (derivative) @ $0 | EDGAR |
| 2025-06-12 | 4 | Astria Therapeutics, Inc. (ATXS) | Grant/award (A): 26,550 (derivative) @ $0 | EDGAR |
| 2025-02-28 | 4 | MADRIGAL PHARMACEUTICALS, INC. (MDGL) | Option exercise (M): 6,000 @ $111.06 · Option exercise (M): 9,470 @ $65.06 · Option exercise (M): 4,530 @ $9.45 · Sale (S): 100 @ $351.01 · Sale (S): 500 @ $351.99 · Sale (S): 238 @ $353.83 · +9 more | EDGAR |
| 2024-06-27 | 4 | MADRIGAL PHARMACEUTICALS, INC. (MDGL) | Grant/award (A): 714 @ $0 · Grant/award (A): 1,105 (derivative) @ $0 | EDGAR |
| 2024-06-06 | 4 | Astria Therapeutics, Inc. (ATXS) | Grant/award (A): 14,100 (derivative) @ $0 | EDGAR |
| 2024-04-03 | 4 | MADRIGAL PHARMACEUTICALS, INC. (MDGL) | Option exercise (M): 10,000 @ $9.45 · Option exercise (M): 10,000 @ $100.45 · Option exercise (M): 1,277 @ $105.08 · Sale (S): 6,698 @ $255.62 · Sale (S): 7,411 @ $256.49 · Sale (S): 2,790 @ $257.33 · +19 more | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1210238 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →